A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.
about
A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@ast
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@en
type
label
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@ast
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@en
prefLabel
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@ast
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@en
P2093
P2860
P1433
P1476
A Novel Physiological Glycosam ...... origenic In Vitro and In Vivo.
@en
P2093
Alain Colige
Christophe Deroanne
Céline Hendricks
Yves Delforge
P2860
P304
P356
10.1371/JOURNAL.PONE.0165153
P407
P577
2016-10-31T00:00:00Z